Acute effects of a beverage containing bitter melon extract (CARELA) on postprandial glycemia among prediabetic adults

Abstract

Background:Acute ingestion of bitter melon (BM) has been shown to suppress the postprandial glycemic response in diabetics, but its impact on glucose regulation among individuals with impaired glucose tolerance is unclear. Moreover, one's glucose tolerance level may influence the effectiveness of BM. This study aimed to examine the acute effects of a beverage containing BM extract on blood glucose regulation during an oral glucose tolerance test (OGTT) among prediabetics.Methods:Ten prediabetic adults completed two OGTTs—glucose only (D2) and glucose+BM (D3). Responders were identified as subjects whose area under the glucose curve (AUCglu) during D3 was lower than D2. To compare the acute effects of the beverage among individuals with varying glucose tolerance levels, subjects were grouped by their glucose response pattern—Fastpeak (peak glucose (Glupeak) at 30 min postglucose (30P)) and Slowpeak (Glupeak after 30P).Results:During D3, responders (n=5) experienced a 13.2% reduction in AUCglu (95% confidence interval (CI): −18.1% to −8.3%), 12.2% reduction in mean glucose (95% CI: −17.3% to −7.0%) and 10.6% reduction in Glupeak (95% CI: −17.5% to −3.7%); plasma glucose was reduced by 9.1% at 30P (95% CI: −15.6% to −2.6%), −24.0% at 60P (95% CI: −36.8% to −11.2%) and −20.0% at 90P (95% CI: −35.8% to −4.2%) during D3. No between-trial differences were noted for Fastpeak or Slowpeak.Conclusions:Acute ingestion of BM prior to the second OGTT (D3) led to a reduced postprandial glucose response in 50% of the subjects but did not affect the insulin response. Furthermore, the effectiveness of the beverage was seemingly uninfluenced by the subjects' glucose tolerance level. Although BM has shown to aid blood glucose management in diabetics, it remains uncertain why only a portion of subjects responded positively to the BM extract in the current study.

An Acute, Placebo-Controlled, Single-Blind, Crossover, Dose-Response, Exploratory Study to Assess the Effects of New Zealand Pine Bark Extract (Enzogenol®) on Glycaemic Responses in Healthy Participants

“…Clinical studies have also revealed that depending on the degree of glucose tolerance in individuals defined by various glucose response indices including glucose curve shapes, they may either be responders or non-responders to a given intervention such as with natural plant extracts [34][35][36][37]. Krishnan and colleagues have also emphasised the importance of examining dietary interventions using an integrated physiological approach that stratified participants with varying glycaemic responses into subgroups in contrast to overall group responses [37].…”

Encapsulated Mulberry Fruit Extract Alleviates Changes in an Animal Model of Menopause with Metabolic Syndrome

“…Our data also demonstrate that when compared to soy isoflavone or genistein which is currently available in the market, MME improves the serum HDL level, atherogenic index, and oxidative stress status better than soy isoflavone does. In addition, MME treatment especially at low and medium doses for 8 weeks also increases glycemic control capability reflected by the reduction in plasma glucose AUC [70]. The possible explanation may be associated partly with the protection of active ingredients such as polyphenolic compound including cyanidins by a core material which is used for encapsulation [71, 72].…”

The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review

“…In 2012, a study focused on 42 metabolic syndrome patients reported that bitter gourd treatment for three months evidently decreased the incidence of metabolic syndrome, which is recognized for predicting T2DM, and the improvement could remain for one month after stopping supplement [ 107 ]. An acute experiment in prediabetic adults exhibited that acute intake of bitter melon beverage led to the reduction of postprandial glucose in 50% of the subjects [ 108 ]. Next year, a RCT on 52 individuals with prediabetes showed that MC intake dropped the blood glucose in participants with higher baseline FBG levels more significantly [ 109 ].…”